ORCHID PHARMA
Back to Balance Sheet
|
ORCHID PHARMA Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹286 Cr | ₹260 Cr | ₹372 Cr | ₹241 Cr | ₹142 Cr |
What is the latest Total Current Liabilities ratio of ORCHID PHARMA ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹286 Cr |
| Mar2024 | ₹260 Cr |
| Mar2023 | ₹372 Cr |
| Mar2022 | ₹241 Cr |
| Mar2021 | ₹142 Cr |
How is Total Current Liabilities of ORCHID PHARMA Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹286 Cr | 9.85 | |
| Mar2024 | ₹260 Cr | -30.09 | |
| Mar2023 | ₹372 Cr | 54.45 | |
| Mar2022 | ₹241 Cr | 69.46 | |
| Mar2021 | ₹142 Cr | - | |
Compare Total Current Liabilities of peers of ORCHID PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ORCHID PHARMA | ₹5,820.8 Cr | -0.5% | -1.4% | 37% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,114.0 Cr | NA | -3.9% | 17.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹239,321.0 Cr | 5% | 21.5% | 44.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,924.0 Cr | -2.1% | -0.2% | 34.3% | Stock Analytics | |
| CIPLA | ₹113,778.0 Cr | -2% | -2.5% | -8.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,025.9 Cr | 0.4% | 4.5% | -4.4% | Stock Analytics | |
ORCHID PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ORCHID PHARMA | -0.5% |
-1.4% |
37% |
| SENSEX | 0.7% |
0.8% |
-5.1% |
You may also like the below Video Courses